AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 149 filers reported holding AMICUS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $37,700,000 | -23.2% | 7,585,493 | +14.3% | 0.01% | -30.0% |
Q3 2016 | $49,097,000 | +55.4% | 6,634,693 | +14.7% | 0.01% | +42.9% |
Q2 2016 | $31,588,000 | -31.3% | 5,785,314 | +6.3% | 0.01% | -36.4% |
Q1 2016 | $46,005,000 | -11.5% | 5,444,399 | +1.6% | 0.01% | -8.3% |
Q4 2015 | $51,999,000 | -28.8% | 5,360,745 | +2.6% | 0.01% | -36.8% |
Q3 2015 | $73,073,000 | +45.5% | 5,223,201 | +47.1% | 0.02% | +58.3% |
Q2 2015 | $50,238,000 | +239.7% | 3,550,362 | +161.2% | 0.01% | +200.0% |
Q1 2015 | $14,788,000 | +40.9% | 1,359,173 | +7.8% | 0.00% | +33.3% |
Q4 2014 | $10,495,000 | +1290.1% | 1,261,378 | +894.0% | 0.00% | – |
Q3 2014 | $755,000 | +152.5% | 126,899 | +41.5% | 0.00% | – |
Q2 2014 | $299,000 | -83.1% | 89,661 | -89.5% | 0.00% | -100.0% |
Q1 2014 | $1,769,000 | -9.3% | 854,639 | +3.0% | 0.00% | 0.0% |
Q4 2013 | $1,951,000 | -40.4% | 830,089 | -41.2% | 0.00% | 0.0% |
Q3 2013 | $3,276,000 | +14.7% | 1,412,103 | +15.2% | 0.00% | 0.0% |
Q2 2013 | $2,856,000 | – | 1,225,659 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |